INO KCL 7.46%

25 ml

DESCRIPTION 
A sterile, colorless and non-pyrogenic solution for intravenous administration.

INDICATIONS 
Treatment of Hypokalemia

DOSAGE AND ADMINISTRATION 
Must always be administered by slow IV infusion, diluted in approximately 30%
concentration, and used in accordance with the condition of each patient. If serum potassium is 2.5 mEq/L or higher, rate should not exceed 10 mEq/hour, and concentration should not exceed 40 mEq/L. Maximum daily dose is 200 mEq.

DRUG MECHANISM 

• Repleting Potassium and chloride in the body.
• Potassium is one of the most important ions in the body and is the major
  intracellular cation. It helps establish the resting membrane potential in
  neurons and muscle fibers after membrane depolarization and action
  potentials. Potassium is also essential in carbohydrate metabolism; it is
  active in glycogen and glucose metabolism, converting glucose to glycogen
  that can be stored in the liver for future energy. Potassium is important for
  normal growth and for building muscle.

CONTRAINDICATIONS 
Do not use for patients with renal failure with oliguria, anuria or azotemia, untreated Addison’s disease, acute dehydration, heat cramps, hyperkalemia, hereditary adynamia episodica.

CAUTION 

• Never give injectable potassium chloride undiluted.
• Dosing must be exercised with caution. Individual doze is based on patient’s serum potassium levels and condition.
• Overdosage will cause Potassium toxicity, which has potential life-threatening hyperkalemia or cardiac arrest.

SIDE EFFECT 
Combining solution with spironolactone and triamterene may cause hyperkalemia.

ATTENTION 
Do not use if the bottle is damaged, has cloudy solution or contains particles.

STORAGE CONDITION 
The product has to be stored below 30°C.

PRESCRIPTION ONLY

PRODUCED BY

PT SATORIA ANEKA INDUSTRI
Jalan Raya Sambisirah, Wonorejo, Pasuruan – Jawa Timur